Redesign Science

Biotechnology ResearchNew York, United States2-10 Employees

Redesign Science is a small biotechnology research company that operates a platform blending physics-based molecular simulation with deep learning to generate drug candidates. It develops first-in-class Protein Interaction Modulators against validated targets known to drive the progression of oncogenic and inflammatory diseases.

Founded in 2017 and based in New York City, New York, the company maintains a compact team. It sits within the biotechnology research industry and emphasizes the integration of computational methods with drug discovery to address disease mechanisms. The work focuses on targets implicated in cancer and inflammatory conditions.

Sign up for free to view info

Email Format Employee directory